Concepedia

Mohamad Cherry

MC

12

Publications

358

Citations

11

H-Index

2014

Active since

Affiliations

Sarah Cannon(Current)

Oklahoma State University Oklahoma City

University of Oklahoma Health Sciences Center

University of Oklahoma

Yale University

Mohamad Cherry is an author at Sarah Cannon specializing in cancer therapeutics, t cell immunity, and tumor immunity.

ORCID

Top concepts

Publications per year

2014–2024

12

Publications

12

Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study

Mohamed A. Kharfan‐Dabaja, Monzr M. Al Malki, Uday Deotare et al. · British Journal of Haematology · 2017 · 83 citations · Full text

Updated Results from a Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Subjects with Newly Diagnosed Acute Myeloid Leukemia (AML)

Keith W. Pratz, Mohamad Cherry, Jessica K. Altman et al. · Blood · 2018 · 58 citations

Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia

Ian W. Flinn, Mohamad Cherry, Michael B. Maris et al. · American Journal of Hematology · 2019 · 40 citations · Full text

Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML

Keith W. Pratz, Mohamad Cherry, Jessica K. Altman et al. · Journal of Clinical Oncology · 2023 · 40 citations · Full text

Incidence of Vascular Thromboembolic Events in Patients Receiving Immunotherapy: A Single Institution Experience

Sami Ibrahimi, Michael Machiorlatti, Sara K. Vesely et al. · Blood · 2017 · 28 citations

Rows per page

1–5 of 12